Skip to Main Content

Paper Details

MEK1/2 inhibitor withdrawal reverses acquired resistance driven by BRAF<sup>V600E</sup> amplification whereas KRAS<sup>G13D</sup> amplification promotes EMT-chemoresistance.
Nat Commun
37
2019
Author NameAffiliation
Jonathan R Dry
David J AdamsWellcome Sanger Institute
Julio Saez-RodriguezEuropean Bioinformatics Institute (EMBL-EBI)
  • 1 - 3

Datasets

Release 1.2